Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Deciphering and Targeting the Synapses between Cancer Cells and Neurons in Pancreatic Cancer

Project description

Nerve-cancer synapses as a new therapeutic target in pancreatic cancer

The nervous system has recently emerged as an active participant in cancer development. Beyond chemical signalling between nerves and tumours, direct synaptic connections have now been discovered between nerve endings and pancreatic cancer cells. These connections are similar to the ones that join neurons and allow cancer cells to hijack neurotransmitters, become responsive to electrical signals from neurons, generate calcium waves, and become more invasive. The ERC-funded SYNAPSE-ON-CANCER project will perform the first real-time analysis of these neuron-cancer networks in pancreatic cancer organoids and human tissue samples. The research team will use two-photon imaging to characterise these synaptic connections and open new therapeutic avenues for one of the most lethal cancers.

Objective

The nervous system has recently been identified to play a central role in cancer pathogenesis, and this discovery has given birth to the burgeoning field of “cancer neuroscience”. Neurons and cancer cells outside the brain are known to communicate over paracrine signals, However, we recently discovered direct synaptic connections between sensory nerve endings and cancer cell membrane in a cancer outside the brain, i.e. pancreatic ductal adenocarcinoma (PDAC). These synaptic sites exhibit a selective enrichment of the glutamatergic NMDA receptor subunit GluN2D on the cancer cells, which enables PDAC cells to hijack the neurotransmitter L-glutamate over these cancer-neuron-synapses. This synaptic input not only aggravates tumor invasiveness and spread in vivo, but, surprisingly, also turns synaptically connected pancreatic cancer cells into electro-responsive, excitable cells via GluN2D-type glutamate receptors at the neuro-cancer synapses. Hence, we now have compelling evidence that pancreatic cancer cells are embedded into synaptically interconnected neuron-cancer networks in the pancreas. In the present study, we will perform the first real-time analysis of the emergence, evolution, function, and plasticity of synaptically interconnected neuron-cancer networks in PDAC. We will perform in vivo two-photon imaging focusing on these synapses in novel, human-like models of PDAC, will dissect their molecular operating mechanisms, and will assess the network activity over the neuron-cancer synapses directly in human PDAC specimens, but also in our novel “innervated organoids”. Finally, we will test the translational potential of the targeting this synaptic interconnection of pancreatic cancer cells with neurons in preclinical trials, coupled with in silico drug repurposing approaches. Therefore, through this comprehensive analysis of neuron-cancer synapses in PDAC, my vision is to open up new avenues for cancer neuroscience-instructed oncological therapies for PDAC.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

KLINIKUM DER TECHNISCHEN UNIVERSITÄT MÜNCHEN (TUM KLINIKUM)
Net EU contribution
€ 1 980 397,50
Address
ISMANINGER STRASSE 22
81675 Muenchen
Germany
Region
Bayern Oberbayern München, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 980 397,50

Beneficiaries (1)